R. Goralczyk et al., Dose dependency of canthaxanthin crystals in monkey retina and spatial distribution of its metabolites, INV OPHTH V, 41(6), 2000, pp. 1513-1522
PURPOSE. TO establish the threshold level of canthaxanthin crystals in the
retina of cynomolgus monkeys. To correlate the spatial distribution of all-
trans canthaxanthin and its metabolites with the grade of crystals.
METHODS. Monkeys were orally administered 0, 0.2, 0.6, 1.8, 5.4, 16.2, and
48.6 mg/kg body wt canthaxanthin daily for 2.5 to 3 years. A second group o
f monkeys were administered 200 and 500 mg/kg body wt/d for 5 years. Ophtha
lmoscopy, electroretinography (ERG), retina and carotenoid analysis were pe
rformed as previously reported.
RESULTS. Crystals in the retina periphery were observed by ophthalmoscopy p
reterminally only in the extreme high doses of 200 to 500 mg/kg body wt/d.
There were no adverse effects on visual functions as measured by ERG. Cryst
als in the peripheral retina, and/or in the macula, were detected microscop
ically in all canthaxanthin treated groups except at the lowest dose of 0.2
mg/kg body wt/d. The grade of crystals increased up to a dose of 16.2 mg/k
g body wt/d. Dose-dependent increases in canthaxanthin content also were no
ted in the retina, the liver, and in plasma. All-trans canthaxanthin was th
e major compound in the peripheral and paracentral retina of very highly do
sed animals, where its concentration correlated largely with the grade of i
nclusions. In the macula, 4'-OH-echinenone was the dominant canthaxanthin m
etabolite.
CONCLUSIONS. The grade of crystals in monkey retinas was dose dependent wit
h a threshold level at 0.6 mg canthaxanthin/kg body wt/d. It correlated in
the retinal periphery with the concentrations of all-trans-canthaxanthin an
d in the macula with its metabolites.